文献速递角膜与眼表疾病

圆锥角膜遗传基础的综合评估:临床转化的新视角

Comprehensive Evaluation of the Genetic Basis of Keratoconus: New Perspectives for Clinical Translation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究通过整合已发表数据与一个独立欧洲队列的新测序数据开展全基因组关联研究,识别出两个与圆锥角膜易感性相关的新遗传位点,并发现315个候选基因,其中MINK1通过WNT信号通路起关键作用。多基因风险评分模型可区分患者与对照(P=7.61E-16;曲线下面积=0.713),药物重定位分析提示乙酰半胱氨酸为潜在治疗选择。

要点

  • 识别出两个与圆锥角膜相关的新遗传位点,先导变异为rs2806689和rs807037。
  • 多基因风险评分模型可区分圆锥角膜患者与对照,曲线下面积=0.713。
  • 药物重定位分析提示乙酰半胱氨酸为圆锥角膜的潜在治疗选择。

核心结论

  • 研究为圆锥角膜的遗传和分子基础提供了重要见解,提供了新的治疗靶点,并强调了多基因风险评分模型在预测疾病风险中的临床效用。

研究设计与样本

  • 全基因组关联研究,整合已发表数据与一个独立欧洲队列的新测序数据。
  • 进行功能注释、基因优先排序、多基因风险评分和药物重定位分析以评估临床转化。

主要发现

  • 识别出两个与圆锥角膜相关的新遗传位点,先导变异为rs2806689(P=1.71E-08,OR=0.88)和rs807037(P=1.93E-08,OR=1.16)。
  • 识别出315个受已确认圆锥角膜相关变异影响的候选基因。
  • MINK1通过WNT信号通路在圆锥角膜发病机制中起关键作用。
  • 多基因风险评分模型可区分圆锥角膜患者与对照(P=7.61E-16;曲线下面积=0.713)。
  • 药物重定位分析识别出乙酰半胱氨酸为圆锥角膜的潜在治疗选择。

关键数值与推荐

  • rs2806689与圆锥角膜相关:P=1.71E-08,OR=0.88。
  • rs807037与圆锥角膜相关:P=1.93E-08,OR=1.16。
  • 多基因风险评分模型区分患者与对照:P=7.61E-16,曲线下面积=0.713。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Keratoconus (KC) is a corneal disorder with complex etiology, apparently involving both genetic and environmental factors, characterized by progressive thinning and protrusion of the cornea. We aimed to identify novel genetic regions associated with KC susceptibility, elucidate relevant genes for disease development, and explore the translational implications for therapeutic intervention and risk assessment. METHODS: We conducted a genome-wide association study (GWAS) that integrated previously published data with newly generated genotyping data from an independent European cohort. To evaluate the clinical translation of our results, we performed functional annotation, gene prioritization, polygenic risk score (PRS), and drug repositioning analyses. RESULTS: We identified two novel genetic loci associated with KC, with rs2806689 and rs807037 emerging as lead variants (P = 1.71E-08, odds ratio [OR] = 0.88; P = 1.93E-08, OR = 1.16, respectively). Most importantly, we identified 315 candidate genes influenced by confirmed KC-associated variants. Among these, MINK1 was found to play a pivotal role in KC pathogenesis through the WNT signaling pathway. Moreover, we developed a PRS model that successfully differentiated KC patients from controls (P = 7.61E-16; area under the curve = 0.713). This model has the potential to identify individuals at high risk for developing KC, which could be instrumental in early diagnosis and management. Additionally, our drug repositioning analysis identified acetylcysteine as a potential treatment option for KC, opening up new avenues for therapeutic intervention. CONCLUSIONS: Our study provides valuable insights into the genetic and molecular basis of KC, offering new targets for therapy and highlighting the clinical utility of PRS models in predicting disease risk.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Cerván-Martín M, Higueras-Serrano I, González-Muñoz S, et al. Comprehensive Evaluation of the Genetic Basis of Keratoconus: New Perspectives for Clinical Translation. Invest Ophthalmol Vis Sci. 2024. PMID: 39436372. doi:10.1167/iovs.65.12.32

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。